medigraphic.com

2021, Number 3

<< Back Next >>

Rev Cuba Endoc 2021; 32 (3)

Quality of life in women with polycystic ovary syndrome, according to the WHOQOL-BREF questionnaire

Ovies CG, Alonso DE, Monteagudo PG, Gómez AM

Language: Spanish
References: 36
Page:
PDF size: 106.33 Kb.


ABSTRACT

Introduction: Polycystic ovary syndrome is clinically characterized by menstrual disorders, anovulatory infertility, as well as clinical and/or biochemical hyperandrogenism. It is frequently associated with type 2 diabetes mellitus, arterial hypertension, dyslipidemia, and risk of cardiovascular disease.
Objective: To assess quality of life of women diagnosed with polycystic ovary syndrome, from their perspective and using a general questionnaire.
Methods: A cross-sectional study was carried out in the period from September 2019 to March 2020, which included 84 women with a diagnosis of the syndrome for less than three months. The questionnaire to assess quality of life called WHOQOL-BREF, prepared by the World Health Organization, was applied to them.
Results: Assessment of global quality of life for 20.2% was low, 15.5% refer that it is bad, and 8.3% of the patients expressed that they were very dissatisfied with their health status. The mean score for this item was 2.81. The mean value of global quality of life of the women studied was 85.2. Consistent with the global quality of life categorized as low, medium or high, in the first case there was 14.3%. 72.6% were within the average rating, and only 13.1% presented a high value for quality of life.
Conclusions: The questionnaire showed a moderate impact on the quality of life in women with the disease, especially in aspects of the physical dimension. Therefore, we consider it important to include the study of aspects related to their quality of life in order to have a more comprehensive care.


REFERENCES

  1. Ovies CG, Verdeja OL, Zamora RH. Frecuencia y características clínicas, hormonales y ultrasonográficas sugestivas del síndrome de ovarios poliquísticos en un grupo de mujeres con síndrome metabólico. Rev Cub Endocrinol. 2008 [acceso: 11/01/2021];19:20-4. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000100004

  2. Saucedo de la Llata E, Moraga MR, Romeu A, Carmona R. Proporción LH-FSH y síndrome de ovario poliquístico: ¿Prueba olvidada o no útil? Ginecol Obstet Mex. 2016 [acceso: 11/01/2021];84:84-94. Disponible en: Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=64904

  3. ESHRE/ASRM-Sponsored Pcwg. Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 [acceso: 11/01/2021];97:41-7. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/14688154/

  4. Schwartzmann L. Calidad de vida relacionada con la salud: aspectos conceptuales. Cienc Enferm. 2003 [acceso: 11/01/2021];9:9-21 Disponible en: Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95532003000200002

  5. Botero BE, Pico ME. Calidad de vida relacionada con la salud (CVRS) en adultos mayores de 60 años: una aproximación teórica. Hacia promoc Salud. 2007 [acceso: 11/01/2021];12:11-24. Disponible en: Disponible en: https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1944

  6. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med. 1996 [acceso: 11/01/2021];334:833-40. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/8596551/

  7. Schumaker S, Elis S, Naughton M. Assissing health-related quality of life in HIV disease: key measurements issues. Qual Life Res. 1997 [acceso: 11/01/2021];6:475-80. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/9330548/

  8. Meeberg GA. Quality of life: a concept analysis. J Advanced Nursing. 1993 [acceso: 11/01/2021];18:32-8. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/8429165/

  9. Castillo A, Arocha C, Castillo I, Cueto M, Armas N. Propuesta de un instrumento para medir calidad de vida relacionada con la salud en instituciones sanitarias cubanas. Rev Cubana Invest Bioméd. 2009 [acceso: 11/01/2021];28:1561-3011. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttex&pid=S0864-03002009000200003&lng=es

  10. Coffey S, Mason H. The Effect of Polycystic Ovary Syndrome on Health-Related Quality of Life. Gynecol Endocrinol. 2003 [acceso: 11/01/2021];17:379-86. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/14710585/

  11. Keegan A, Liao LM, Boyle M. Hirsutism: A psychological analysis. J Health Psychol. 2003 [acceso: 11/01/2021]8:327-45. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/14670212/

  12. Hanna S, Klotz J. Acne Vulgaris: More than skip deep. J Dermatol. 2003 [acceso: 11/01/2021];9:3-8. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/12952755/

  13. Fallas M. Cambios Menstruales en el Síndrome de ovario Poliquístico. Rev Med Costa Rica Centroam. 2015 [acceso: 11/01/2021];614:87-90 Disponible en: Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=58578

  14. Elsenbruch S, Hahn S, Kowalsky D, Öffner A, Schedlowski M, Mann K, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003 [acceso: 10/02/2021];88: 5801-07. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/14671172/

  15. Hahn S, Janssen O, Tan S, Pleger K, Mann K, Schedlowski M. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrine. 2005 [acceso: 10/02/2021];153:853-60. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/16322391/

  16. World Health Organization. WHOQOL-BREF Introduction, administration, scoring and generic version of the assessment. WHO. 1996. [acceso: 10/02/2021]. Disponible en: Disponible en: https://apps.who.int/iris/handle/10665/63529?locale-attribute=es&mode=simple

  17. Trent M, Rich M, Austin B, Gordon C. Quality of Life in Adolescent Girls with Polycystic Ovary Syndrome. Arch Pediatr Adolesc Med. 2002 [acceso: 10/02/2021];156:556-66. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/12038887/

  18. Schmid J, Kirchengast S, Vytiska E, Huber J. Infertility caused by PCOS-health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod. 2004 [acceso: 10/02/2021];19:2251-57. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/15333601/

  19. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women´s quality of life: More than an endocrine disorder. Drug Healthc Patient Saf. 2009 [acceso: 10/02/2021];1:9-15. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/21701605/

  20. Muñoz L, Villa L, Araya A, Urrutia M. Calidad de vida en mujeres con síndrome de ovario poliquístico. Horiz Enferm. 2010 [acceso: 10/02/2021];21:11-8. Disponible en: Disponible en: http://www.revistadisena.uc.cl/index.php/RHE/article/view/12726

  21. Blay S, Aguiar J, Cavalcante I. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatric Dis Treat. 2016 [acceso: 10/02/2021];12:2895-2903. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/21701605/

  22. Sahingöz M, Uguz F, Gezginc K, Korucu DG. Axis I and Axis II diagnoses in women with PCOS. Gen Hosp Psychiatry. 2013 [acceso: 10/02/2021];35:508-11. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/23726743/

  23. Asik M, Altinbas K, Eroglu M. Evaluation of affective temperament and anxiety-depression levels of patients with polycystic ovary syndrome. J Affect Dis. 2015 [acceso: 10/02/2021]185:214-8. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/26241866/

  24. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007 [acceso: 10/02/2021];87:1369-76. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/17397839/

  25. Sidra S, Haseeb M, Junaid M, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS One. 2019 [acceso: 10/02/2021];14. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31603907/

  26. Chaudhari A, Mazumdar K, Mehta P. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018 [acceso: 13/02/2021];40:239-46. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968645/

  27. Stefanaki C, Bacopoulou F, Livadas S, Kandaraki A, Karachalios A, Chrousos G, et al. Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial. Stress. 2015 [acceso: 13/02/2021];18:57-66. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/25287137/

  28. Cooney LG, Milman LW, Hantsoo L, Kornfield S, Sammel MD, Allison KC, et al. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertility and Sterility. 2018 [acceso: 13/02/2021];110:161-72. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443091/

  29. Carazo B, Lafalla O, García R, Gascón E, Moreno E, Rojas B. Calidad de vida relacionada con la salud en mujeres con ovario poliquístico. Medisur. 2014 [acceso: 13/02/2021]12:408-15. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2014000200007

  30. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Sexual functioning among married Iranian women with polycystic ovary syndrome. Int JFertil Steril. 2014 [acceso: 13/02/2021];8:273-80. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221514/

  31. Rzonca E, Bien A, Wdowiak A, Szymariski R, Iwanowicz P. Determinants of Quality of Life and satisfaction with Life in Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health. 2018 [acceso: 13/02/2021];15:376-85. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858445/

  32. Benhboodi Z, Fereidonni B, Saffori M, Montazen A. Measures of health-related quality of life in PCOS women: a systematic review. Inter J Wom Health. 2018 [acceso: 13/02/2021]10:397-408. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/30123008/

  33. Huang HT, Chen PC, Wu MH, Lin CY. Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome. Health Qual Life Outcomes. 2016 [acceso: 13/02/2021];1614:9. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995650/

  34. Benetti CL, Ferreira SR, Antunes A, Yela DA. The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2015 [acceso: 13/02/2021];291:451-5. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/25138126/

  35. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol. 2005 [acceso: 13/02/2021];152:986-92. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/15888157/

  36. Lipton MG, Sherr L, Elford J, Rustin MH, Clayton WJ. Women living with facial hair: the psychological and behavioral burden. J Psychosom Res. 2006 [acceso: 13/02/2021];61:161-8. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/16880018/




2020     |     www.medigraphic.com